Elevance Health SG&A increased by 16.9% to $6.33B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.4%, from $5.30B to $6.33B. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 7.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 22, 2026
How to read this metric
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Detailed definition
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Peer comparison
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
Metric ID:
selling_general_and_administrativeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.82B | $3.95B | $4.23B | $4.35B | $4.27B | $4.52B | $4.57B | $4.80B | $4.82B | $5.47B | $5.00B | $4.89B | $5.07B | $5.27B | $4.80B | $5.30B | $5.00B | $5.27B | $5.42B | $6.33B |
| QoQ Change | — | +3.3% | +7.1% | +2.8% | -1.7% | +5.7% | +1.1% | +5.1% | +0.4% | +13.5% | -8.6% | -2.3% | +3.7% | +4.0% | -8.8% | +10.3% | -5.7% | +5.5% | +2.7% | +16.9% |
| YoY Change | — | — | — | — | +11.8% | +14.4% | +8.1% | +10.5% | +12.8% | +21.1% | +9.5% | +1.8% | +5.1% | -3.7% | -3.9% | +8.5% | -1.4% | +0.1% | +12.7% | +19.4% |
Range$3.82B – $6.33B
CAGR+11.2%
Avg YoY Growth+7.9%
Median YoY Growth+9.0%
Current Streak3 quarters growth
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Health Benefits | $4.82B | $4.54B | $4.80B | $4.89B | $4.88B |
| Corporate & Other | $295.00M | $295.00M | $226.00M | $0.00 | $1.12B |
| Carelon Services | $726.00M | $751.00M | $756.00M | $840.00M | $810.00M |
| CarelonRx | $230.00M | $223.00M | $232.00M | $220.00M | $188.00M |
| Total | $5.30B | $5.00B | $5.27B | $5.42B | $6.33B |
SG&A at Other Companies
Frequently Asked Questions
- What is Elevance Health's sg&a?
- Elevance Health (ELV) reported sg&a of $6.33B in Q1 2026.
- How has Elevance Health's sg&a changed year-over-year?
- Elevance Health's sg&a increased by 19.4% year-over-year, from $5.30B to $6.33B.
- What is the long-term trend for Elevance Health's sg&a?
- Over 4 years (2021 to 2025), Elevance Health's sg&a has grown at a 7.2% compound annual growth rate (CAGR), from $15.92B to $20.98B.
- What does sg&a mean?
- The overhead costs of running the business, including sales, marketing, and general corporate expenses.